Home › Funds › Millennium Management › ABUS
Millennium Management position in ABUS
ARBUTUS BIOPHARMA CORP · Health Care
Latest position (Q1 2026)642.45K sh
Reported value held$2.89M
Portfolio Weight0.00%
First reportedQ3 2021
Last changeNew
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 1.17M | $5.03M | New |
| Q4 2021 | 3.04M | $11.82M | Add |
| Q1 2022 | 2.02M | $6.01M | Reduce |
| Q2 2022 | 4.16M | $11.27M | Add |
| Q3 2022 | 3.51M | $6.70M | Reduce |
| Q4 2022 | 1.85M | $4.32K | Reduce |
| Q1 2023 | 1.66M | $5.03K | Reduce |
| Q2 2023 | 1.70M | $3.92M | Add |
| Q3 2023 | 1.58M | $3.21M | Reduce |
| Q4 2023 | 1.54M | $3.84M | Reduce |
| Q1 2024 | 242.21K | $624.91K | Reduce |
| Q2 2024 | 208.97K | $645.71K | Reduce |
| Q3 2024 | 250.96K | $966.20K | Add |
| Q4 2024 | 343.03K | $1.12M | Add |
| Q1 2025 | 348.22K | $1.22M | Add |
| Q2 2025 | 499.48K | $1.54M | Add |
| Q3 2025 | 528.34K | $2.40M | Add |
| Q1 2026 | 642.45K | $2.89M | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding ABUS
- Morgan Stanley 17.70M sh · $84.95M · Q2 2026
- BlackRock Inc 13.77M sh · $66.08M · Q2 2026
- Vanguard Group 9.24M sh · $44.46M · Q4 2025
- Geode Capital Management 4.12M sh · $19.77M · Q2 2026
- Goldman Sachs Group 3.51M sh · $16.83M · Q2 2026
- Bank of America Corp 2.65M sh · $12.70M · Q2 2026
- Legal & General Investment Management America 2.47M sh · $11.84M · Q2 2026
- Charles Schwab Investment Management 1.43M sh · $6.87M · Q2 2026
- Northern Trust Corp 1.42M sh · $6.81M · Q2 2026
- Citigroup Inc 879.24K sh · $4.22M · Q2 2026
- Arrowstreet Capital 650.70K sh · $3.12M · Q2 2026
- Wellington Management Group 461.65K sh · $2.22M · Q2 2026